XCELLentis Overview

  • Founded
  • 2001


  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

XCELLentis General Information


Developer of wound healing treatments. The company develops clinical stage pipeline products for the treatment of chronic, hard-to-heal wounds.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Verlorenbroodstraat 120
  • 9820 Merelbeke
  • Belgium

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XCELLentis Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore XCELLentis‘s full profile, request access.

Request a free trial